CTLA4 and neoplasm: Following culture of these cells for 3 days with or without either a-CTLA4-TGFβRII or a-CTLA-4, tumor antigen-reactive T cells (CD3+/CFSElow/IFNγ+) were quantified by immunophenotype analyses (Fig. 3d).